Francesca Fontana Selected Research

Francesca Fontana Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 11/2015
5	Multiple Myeloma 09/2021 - 03/2009
4	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2015
3	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2015
3	Circulating Neoplastic Cells 01/2021 - 11/2014
2	Weight Gain 02/2024 - 01/2024
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 01/2024
2	Obesity 02/2024 - 01/2024
2	Dementia (Dementias) 01/2023 - 01/2015
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
2	Triple Negative Breast Neoplasms 01/2021 - 11/2015
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 01/2015
1	Virus Diseases (Viral Diseases) 01/2022
1	COVID-19 01/2022
1	Infections 01/2022
1	Melanoma (Melanoma, Malignant) 10/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Hyperglycemia 01/2021
1	Glucose Intolerance 01/2021
1	Osteolysis 01/2021
1	Insulin Resistance 01/2021
1	Disease Progression 01/2018
1	Feeding and Eating Disorders (Eating Disorder) 11/2017
1	Asphyxia (Suffocation) 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Starvation 06/2013
1	Psychotic Disorders (Schizoaffective Disorder) 05/2012
1	Anorexia Nervosa 05/2006
1	Hepatocellular Carcinoma (Hepatoma) 07/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2002
3	IntegrinsIBA 01/2021 - 01/2016
2	Connexin 43 (Connexin43)IBA 02/2024 - 01/2024
2	IronIBA 01/2023 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
2	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2021
2	Bortezomib (Velcade)FDA Link 09/2021 - 06/2013
2	LipidsIBA 01/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2016
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2023
1	Chelating AgentsIBA 01/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2023
1	heparanaseIBA 01/2022
1	roneparstatIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	VaccinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Arginine (L-Arginine)FDA Link 10/2021
1	ArginaseIBA 10/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021
1	Cell Adhesion MoleculesIBA 06/2021
1	Cadherins (E-Cadherin)IBA 06/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	MicellesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	Integrin alpha4beta1 (VLA-4)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	tdTomatoIBA 01/2020
1	RhodaminesIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	CrizotinibIBA 01/2019
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 11/2017
1	Acetates (Acetic Acid Esters)FDA Link 01/2017
1	ParaffinIBA 02/2016
1	Formaldehyde (Formol)FDA Link 02/2016
1	ProgranulinsIBA 01/2016
1	CilengitideIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 11/2015
1	EpitopesIBA 11/2015
1	POL5551IBA 11/2015
1	eribulin FDA Link 11/2015
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Ferritins (Ferritin)IBA 06/2013
1	Polytetrafluoroethylene (Teflon)FDA Link 05/2012
1	ElementsIBA 05/2012
1	Proteasome InhibitorsIBA 03/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2009

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2014
4	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
2	Neoadjuvant Therapy 01/2023 - 01/2021
1	Immunotherapy 10/2021
1	Secondary Prevention 01/2020
1	Aftercare (After-Treatment) 01/2017
1	Precision Medicine 02/2016
1	Enteral Nutrition (Feeding, Tube) 05/2006